Multimodal analyses of immune cells during bone repair identify macrophages as a therapeutic target in musculoskeletal trauma

Yasmine Hachemi,Simon Perrin,Maria Ethel,Anais Julien,Julia Vettese,Blandine Geisler,Christian Göritz,Céline Colnot

DOI: https://doi.org/10.1101/2024.04.29.591608

2024-05-01

Abstract:Musculoskeletal traumatic injuries (MTI) involve soft tissue lesions adjacent to a bone fracture leading to fibrous nonunion. The impact of MTI on the inflammatory response to fracture and on the immunomodulation of skeletal stem/progenitor cells (SSPCs) remains unknown. Here, we used single cell transcriptomic analyses to describe the immune cell dynamics after bone fracture and identified distinct macrophage subsets with successive pro-inflammatory, pro-repair and anti-inflammatory profiles. Concurrently, SSPCs transition via a pro- and anti-inflammatory fibrogenic phase of differentiation prior to osteochondrogenic differentiation. In a preclinical MTI mouse model, the injury response of immune cells and SSPCs is disrupted leading to a prolonged pro-inflammatory phase and delayed resolution of inflammation. Macrophage depletion improves bone regeneration in MTI demonstrating macrophage involvement in fibrous nonunion. Finally, pharmacological inhibition of macrophages using the CSF1R inhibitor Pexidartinib ameliorates healing. These findings reveal the coordinated immune response of macrophages and skeletal stem/progenitor cells as driver of bone healing and as a primary target for the treatment of trauma-associated fibrosis.

Physiology

What problem does this paper attempt to address?

The paper attempts to address the following issues:

1. **The impact of musculoskeletal trauma (MTI) on the inflammatory response during fracture healing**: Musculoskeletal trauma involves not only bone injury but also soft tissue damage, which may lead to fibrous nonunion. However, how MTI affects the inflammatory response after fracture and the regulatory role of immune cells on skeletal stem/progenitor cells (SSPCs) remains unclear.

2. **Immune cell dynamics and their relationship with SSPCs**: Through single-cell transcriptome analysis, the paper describes the dynamic changes of immune cells after fracture, particularly the role of different macrophage subtypes in the fracture healing process. The study found that SSPCs undergo a transition from pro-inflammatory to anti-inflammatory states after fracture, a process closely related to the dynamic changes of macrophages.

3. **The role of macrophages in MTI**: The study found that in the MTI model, the inflammatory response of immune cells and SSPCs is disrupted, leading to a prolonged pro-inflammatory phase and delayed resolution of inflammation. By genetically knocking out or pharmacologically inhibiting macrophages, bone healing in MTI can be improved, indicating that macrophages play a key role in MTI-induced fibrous nonunion.

4. **Therapeutic potential of targeting macrophages**: The paper explores the potential of improving bone healing after MTI by inhibiting macrophage function through the CSF1R inhibitor Pexidartinib. The results show that Pexidartinib can significantly reduce fibrotic accumulation and promote the formation of mineralized bone and cartilage, thereby improving bone healing.

In summary, the paper aims to reveal the dynamic changes of macrophages during fracture healing and their impact on SSPC differentiation, and proposes targeting macrophages as a new strategy to treat MTI-induced fibrous nonunion.